Tuesday, August 17, 2021: Neuberg Diagnostics, India’s fourth-largest diagnostic lab chain, today announced that it has partnered with ace cricketer, MS Dhoni, for creating awareness about Neuberg’s health and wellness campaign and conveying its efforts towards empowering every citizen with better and affordable healthcare.

Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics, said, “MS Dhoni complements our growth mindset, and thus is a strategic fit during our growing years. We are excited about this association and are honored to have him on board as our evangelist and global brand ambassador. We are keen to take our plethora of diagnostic services across the country and convey our efforts towards empowering every citizen with better and affordable healthcare. Furthermore, Dhoni’s commitment towards maintaining good health and fitness resonates well with our mission and will remind people to prioritize their health. Dhoni’s backing will enable us to communicate about our commitment and services more effectively.”

MS Dhoni, Former India Skipper and Captain of Chennai Super Kings, said, “The leaders at Neuberg are committed to providing affordable healthcare across India, and that really struck me and it’s a pleasure to be associated with the team and their various programs aimed at providing access to quality and affordable healthcare. Amidst the Covid-19 pandemic, they have taken up the campaign to raise awareness about health and wellness across age groups. I personally feel that these efforts are important and deserve to be advocated.”

On the back of growing footprints, the company has been seeing robust growth. In a matter of four years since its inception, with a presence in three continents, the company ended its FY21 with revenues of Rs.800 crore, and on the back of its differentiated offerings, it is aiming to close FY22 with revenues of Rs.1000 crore with more than 200 labs and 3000 collection centers, located across the world.

MS Dhoni will also enable the company to generate recall across its global markets in the UAE, South Africa, and the USA.

About Neuberg Diagnostics:

The best-in-class laboratories across India, the UAE, South Africa, and the USA have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries. Utilizing their combined strengths, Neuberg Diagnostics brings capabilities to perform over 6000 varieties of pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs, and Structured Disease Management programs for rare diseases using the most advanced technologies, assisted by data science and AI tools.

Since its inception, besides starting greenfield labs, it had also acquired Anand Diagnostic Laboratory in Bengaluru, Supratech Micropath Laboratory in Ahmedabad, Ehrlich Laboratory in Chennai, and A.G. Diagnostics Laboratory in Pune, to expand its presence across India. In addition, it has also acquired Global Labs in South Africa and Minerva Diagnostics in Dubai, to expand its footprint in the global arena.

With 14 approved labs for COVID-19 testing in India, it has the capability to process more than 65,000 COVID samples in a day.

Some of the best Pathologists, Biochemists, Geneticists, Microbiologists, and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge, and using the latest generation of diagnostic techniques to take accurate and timely diagnoses to the next level.

Currently, Neuberg Diagnostics has over 120 labs and 1000 touchpoints across 4 countries. Neuberg Diagnostics also provides Hospital Laboratory Management Services, Preventive Health Checks, Corporate Wellness, Home Health Services, and Drive-through Phlebotomy Services.

The post Neuberg Diagnostics partners with MS Dhoni to send the message of health and wellness appeared first on PuneDiary.Com.

• Owing to reverse smoking, high lung cancer incidences seen in women
• 80-85% of patients continue to report lung cancer at advanced stages
• Targeted tissue therapy fast becoming the best alternative to chemotherapy for cancer treatment   
• The life expectancy of lung cancer patients has increased from less than a year to 3-5 years with the help of genetic testing even in advanced Stage cancer

 India, Friday, July 30, 2021: Ahead of World Lung Cancer Day, the lung cancer experts at Neuberg Centre for Genomic Medicine Panel discussion on Lung Cancer Detection – How Late, is Late? shared the insights that lately, an increasing number of women are reporting cases of lung cancer. The lung cancer incidences in men continue to be high, however, the rising number of incidences in women has become a cause of concern.

According to experts, weight loss, sputum production, cough, coughing blood are some of the prominent symptoms of lung cancer. Once cancer spreads from the lungs, it can go to the liver causing jaundice, spread to the adrenal glands causing them to fail, resulting in a low-BP emergency, pain, and fracture in bones and stroke or seizures when cancer reaches the brain.

Consuming cigarettes, tobacco chewing, kheni, hookah, betel leaf with tobacco, reverse smoking, household, and traffic pollutants,  are the main causes of lung cancer, apart from occupational factors such as working in industries, mining sector, etc. The disease burden of tobacco-related malignancies is expected to rise by 12 percent in India in the next few years, the panelists stated.

Dr. (Brig) S. Viswanath, Medical Oncologist, Kumaran Hospital, said, “Most of the times lung cancer is mistaken for tuberculosis in the earlier stages as the symptoms of both the diseases are very similar. In both cases, a patient experiences coughing and or coughing up blood. Smoking continues to be a major cause of lung cancer, the risk of developing lung cancer in smokers versus non-smokers is 20:1. A passive smoker has an increased chance of contracting cancer than a smoker. For treating the patient at the early stage, surgery is the most important method followed by radiotherapy. Now, more advanced therapy like targeted therapy and immunotherapy options are available which increases overall survival and leads to a  better quality of life. Targeted and immunotherapies have fewer side effects compared to chemotherapy. Genetic testing has been a boon in deciding the therapy options leading to better survival rates. ”

 Dr. Jagannath Dixit, Consultant Surgical Oncology, HCG Cancer Hospital, said, “50% of the lung cancer patients die in the first year post-diagnosis. We can ensure a 14% to 20% decrease in deaths if the cancer is detected at the earlier stages. However, early symptoms are less visible, hence it is difficult to detect lung cancer at early stages. Reverse smoking has come across as a major cause of lung cancer among  rural women, especially those who work in the field in northern Karnataka.”

Dr.Dixit emphasized having multidisciplinary care for patients with cancer where surgical, medical, molecular pathologist , and genetic counselors contribute. There has been a drastic shift in the survival rate after the advent of targeted therapy and genetic testing.

Dr. Siddharth Srivastava, Chief Scientist (Molecular Oncology), Neuberg Center of Genomic Medicine, said, “Targeted therapy has emerged as an important method to treat cancer. Targeted therapies act on specific molecular targets associated with cancer, whereas most standard chemotherapies act on all rapidly dividing normal and cancerous cells, which also kill normal cells. Targeted therapy is known to cause lesser side effects as compared to chemotherapy while improving quality of life of patients.”

About Neuberg Diagnostics:

Best-in-class laboratories across India, the USA, UAE & South Africa have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries. Utilizing their combined strengths, the Neuberg brings capabilities to perform over 6000 varieties of Pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs , and Structured Disease Management programs for rare diseases using the most advanced technologies assisted by Data science and AI tools.

Today, Neuberg Diagnostics is among the top diagnostics companies of Indian origin and the fastest growing healthcare start-up in India. With 18 approved labs for Covid testing in India, the USA , and South Africa, the group has more than 65000 COVID testing capacity in India. Some of the best Pathologists, Biochemists, Geneticists, Microbiologists , and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge and using the latest generation of diagnostics techniques to take accurate and timely diagnoses to the next level.

Currently , the group has over 120 labs and over 1000 touchpoints across 4 countries. Our Indian Expansion plans include setting up a network of 500 collection centers across the country within the next 12 months. Our overseas expansion plans include establishing a presence in East Africa, West Africa, Sri Lanka, Nepal, Bangladesh, the USA and Germany.

Neuberg also provides Hospital Laboratory Management Services, Preventive Health Checks, Corporate Wellness, Home Health Services and Drive through Phlebotomy Services.

The post Number of lung cancer incidences on rise in women, says panelists at Neuberg Centre for Genomic Medicine appeared first on PuneDiary.Com.

July 13, 2021: India’s fourth-largest pathology player, Neuberg Diagnostics Private Limited inaugurated a new state-of-the-art pathology lab in Khammam, Telangana. The commencement of operations of the new lab in Khammam, Telangana is another step of Neuberg Diagnostics’ towards expanding its domestic and international presence. Last year, it had entered eastern and northern states by setting up greenfield labs and is expecting to be a significant player in those markets in this financial year. It had also set up a CLIA approved molecular and genomic lab in the USA, in FY 22 with COVID testing facilities.

The new lab was inaugurated by SH. Puvvada Ajay Kumar, Minister of Transport, Telangana Government and SH. Nama Nageshwar Rao, local MP, TRS Party, SH. Errabelli Dayakar Rao, Minister of Panchayat Raj & Rural Development, Telangana.

The group had closed FY 21 with gross revenue of INR 800 crore. As a part of the expansion plan in FY22, Neuberg will be launching 30 new labs and more than 500 collection centers in domestic and international markets. It will also be putting up technology incubation centers in the USA and Europe to access the latest technologies and make developing countries ready for precision diagnostics in the evolving personalized medicine arena.

*Mr. A Ganesan, Group Vice Chairman, Neuberg Diagnostics said*, “Apart from inorganic growth, we are also setting up greenfield labs and mobile COVID testing units in order to increase the reach of quality testing in small towns in India. In terms of international expansion, we are looking to expand rapidly in the USA and also planning to open diagnostics facilities in East Africa and in West Asia,  We will be commissioning a new state of art testing facility in Dubai which will act as a hub in West Asia. We are also planning to have our presence in Sri Lanka, Nepal, Bangladesh, and Germany during this Financial year “

Speaking on the development, *MS. Aishwarya Vasudevan, Group Chief Operating Officer, Neuberg Diagnostics Private Limited, said*, “The 2nd wave of covid had a major impact on the Indian healthcare ecosystem. There is a demand for superior healthcare services, right from diagnosis to treatment, in Tier II & III cities…our efforts are directed towards filling this gap. This new lab at Khammam is an important milestone in Neuberg’s vision to help the battle against disease by making available the most advanced diagnostics tests within the reach of the common man across the globe, with a relentless focus on quality, cutting-edge technology, and uncompromising ethics.”

Currently, Neuberg Diagnostics has 109 labs in India and 15 labs overseas (USA, South Africa, and Dubai). With 14 approved labs for Covid testing in India, the group has the capacity to process more than 65000 tests per day. Additionally, the group is also doing COVID tests from 3 of its labs in South Africa and 1 in the USA.

About Neuberg Diagnostics:

Best-in-class laboratories across India, the USA, UAE & South Africa have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries. Utilizing their combined strengths, the Neuberg brings capabilities to perform over 6000 varieties of Pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs, and Structured Disease Management programs for rare diseases using the most advanced technologies assisted by Data science and AI tools.

Today, Neuberg Diagnostics is among the top diagnostics companies of Indian origin and the fastest growing healthcare start-up in India. With 18 approved labs for Covid testing in India, the USA, and South Africa, the group has more than 65000 COVID testing capacity in India. Some of the best Pathologists, Biochemists, Geneticists, Microbiologists, and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge and using the latest generation of diagnostics techniques to take accurate and timely diagnoses to the next level.

Currently, the group has over 120 labs and over 1000 touchpoints across 4 countries. Our Indian Expansion plans include setting up a network of 500 collection centers across the country within the next 12 months. Our overseas expansion plans include establishing a presence in East Africa, West Africa, Sri Lanka, Nepal, Bangladesh, the USA, and Germany.

Neuberg also provides Hospital Laboratory Management Services, Preventive Health Checks, Corporate Wellness, Home Health Services, and Drive through Phlebotomy Services.

The post Neuberg Diagnostics expands its Presence in India with inauguration of a new lab in Telangana appeared first on PuneDiary.Com.

• The chances of people developing mucormycosis (black fungus) post taking the vaccine are lower
• With herd immunity, the severity of 3^rd wave will be less severe than 2^nd wave
• Delta plus variant remains the cause of concern
• Antibodies produced by the vaccine protect against Covid-19 complications, blood clotting, and secondary infections
• People would require a flu-like booster shot every year to pep-up immunity

India, Friday, July 9, 2021: The panelists at Neuberg Diagnostics’ Panel discussion on ‘Covid-19: Lessons Learnt and Planning Forward’, echoed the sentiment that Delta plus Covid-19 variant continues to be a cause of concern and quick vaccination is the only weapon we have at hand. Immediate vaccination will enable us to achieve herd immunity while also reducing the chances of black fungus, severe health complications, side effects, blood clots, and secondary infections. The panelists also expressed the concern that if we lower our guard, then the third wave is imminent and will likely begin in August and peak in November.

Professor and Padma Shri awardee Dr. Mohan Kameswaran, Otorhinolaryngologist, Founder, Madras ENT Research Foundation, Chennai, said, “We witnessed the first case of Mucormycosis (black fungus – severe and rare fungal infection) in March, the cases peaked from 2 to 3 in March to 10 to 15 cases in May, with a mortality rate of 40 percent to 50 percent. Although high, it is not as high as anticipated. The major issue is the lack of relevant drugs to treat Mucormycosis. In Tamil Nadu area, the spread of Mucormycosis became epidemic within pandemic.”

He added, “60 percent to 70 percent of the patients who came to me with black fungus had not taken the vaccine, 25-30 percent had taken one dose, and less than 5 percent had taken both doses. Thus, people who have taken both doses have a good chance against Covid-19 infection and are much less prone to black fungus.”

On the third wave, Dr. Rajinder Kumar Singal, Senior Director & HOD – Internal Medicine, BLK Max Hospital, New Delhi, said, “We are still not out of the second wave but are ready for the third wave. The third wave is expected to be less severe than the second wave due to increased vaccination. About 21% of the Indian population has received the first dose, and 4% has received both vaccine doses. However, quick vaccination, Covid-19 appropriate behavior and absence of super spreader events will be key to stop the spread of the infection.”

Dr. Bhavini Shah, Director, Neuberg Centre of Genomic Medicine, Ahmedabad, said, “Antibody tests on hundreds of people vaccinated with the second dose of a Covid-19 vaccine indicate that booster shots may be required for the population. The findings were made after checking antibody levels of nearly 30,000 people in Gujarat by us. Out of these numbers, researchers focused on 500 healthcare workers. We found that people would require a flu-like booster shot every year to pep-up immunity.”

Dr. Hemalata Arora, General Physician & Infectious Disease Specialist, Nanavati Max Super Speciality Hospital, Mumbai, said, “Antibodies produced by the vaccine protect against Covid, complications, side-effects, blood clotting, secondary infections; hence one must get vaccinated.”

She added, “Studies are being done on using mRNA vaccines for booster doses rather than taking the same DNA vaccines we took the first and second time. Mixing might be more appropriate, though there may be some side effects. More India-based studies are required on this.”

About Neuberg Diagnostics:

Best-in-class laboratories across India, the USA, UAE & South Africa have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries. Utilizing their combined strengths, the Neuberg brings capabilities to perform over 6000 varieties of Pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs, and Structured Disease Management programs for rare diseases using the most advanced technologies assisted by Data science and AI tools.

Today, Neuberg Diagnostics is among the top diagnostics companies of Indian origin and the fastest growing healthcare start-up in India. With 18 approved labs for Covid testing in India, the USA, and South Africa, the group has more than 65000 COVID testing capacity in India. Some of the best Pathologists, Biochemists, Geneticists, Microbiologists, and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge and using the latest generation of diagnostics techniques to take accurate and timely diagnoses to the next level.

Currently, the group has over 120 labs and over 1000 touchpoints across 4 countries. Our Indian Expansion plans include setting up a network of 500 collection centers across the country within the next 12 months. Our overseas expansion plans include establishing a presence in East Africa, West Africa, Sri Lanka, Nepal, Bangladesh, the USA, and Germany.

Neuberg also provides Hospital Laboratory Management Services, Preventive Health Checks, Corporate Wellness, Home Health Services, and Drive through Phlebotomy Services.

The post Vaccine reduces chance of black fungus, Experts at Neuberg Diagnostics Panel appeared first on PuneDiary.Com.